Meta-analysis

Vaginal misoprostol (Prostin®) for intrauterine insemination: Α meta – analysis of randomized trials

Pergialiotis Vasilios, Frountzas Maximos, Stefanidis Konstantinos, Prodromidou Anastasia, Perrea Despina, Vlachos D Georgios

Introduction: The seminal fluid contains prostaglandins which seem to be important during the fertilization process. However, these are cleaved during semen preparation for intrauterine insemination (IUI). The purpose of the present meta – analysis is to investigate if vaginal application of prostaglandin E (PGE) improves the pregnancy rates among women undergoing IUI.

Case Report

Cesarean scar pregnancy: A diagnostic dilemma and management with suction curettage

Syed Rifat, Sinha Prabha, El – Halwagy Hosam, Brompton Wendy

A case of a cesarean section scar pregnancy with a diagnostic dilemma is presented. Due to a decrease in β – hCG after 48 hours, the patient was diagnosed with a failing pregnancy and was given misoprostol. However, β – HCG was still high and the patient had a severe vaginal bleeding after a month of medical management. Evacuation curettage under laparoscop …

Review

First trimester medical abortion: The several merits of combination mifepristone – misoprostol

Vrachnis Nikolaos, Zygouris Dimitrios, Lolos Markos, Dimitrakaki Alexandra, Salakos Nikolaos

Abortion is a very common procedure among women of reproductive age. Medical abortion is an alternative to surgical evacuation, especially in the early first trimester. Following the introduction of mifepristone, the number of medical abortions has rapidly increased. Mifepristone is used at doses of either 600mg or 200mg in combination with misoprostol and is regarded as a safe…